Results 91 to 100 of about 912,520 (207)

Meningococcal infections among refugees and immigrants: silent threats of past, present and future. [PDF]

Hum Vaccin Immunother, 2020
Dinleyici EC, Borrow R.
europepmc   +1 more source

Serogroup B meningococcal vaccine booster doses [PDF]

Meningococcal-2-Mbaeyi-508 ...

core  

Serosubtipos de meningococo B causantes de enfermedad invasiva en Cantabria y concordancia con la cepa de la vacuna cubana Meningococcus B serosubtypes causing invasive disease in Cantabria [Spain] and agreement with the Cuban vaccine strain

Gaceta Sanitaria, 2004
Objetivo: Conocer los serosubtipos de meningococo B causantes de enfermedad invasiva en Cantabria y el porcentaje de concordancia con la cepa de la vacuna cubana VA-Mengoc-BC.
Álvaro González de Aledo, Luis Viloria
doaj  

Updated ACIP statement for meningococcal vaccination in the United States [PDF]

Meningococcal-3-Mbaeyi-508 ...

core  

Meningococcal ACWY vaccine [PDF]

Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood.

core  

A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections.

PLoS ONE
The genus Neisseria includes two major human pathogens: N. meningitidis causing bacterial meningitis/septicemia and N. gonorrhoeae causing gonorrhoea.
Soeren Metelmann, Alexander Thompson, Anna Donten, Segun Oke, Suzy Sun, Ray Borrow, Feng Xu, Roberto Vivancos, Valerie Decraene, Lorenzo Pellis, Ian Hall   +10 more
doaj   +1 more source

Meningoccocal meningitis complicated with subdural effusion: a report of two infant cases

Journal of Infection in Developing Countries, 2007
Neisseria meningitidis is a major cause of invasive bacterial infection in children of all ages. Children less than 1 year of age are at greater risk of invasive disease than older children. In endemic countries, the invasive meningococcal infections are
Victor Perez-Pico,1 Eduardo Llausas-Magana,1 Angel Leon-Ramirez,1 Giordano Perez-Gaxiola,2 and Nidia Leon-Sicairos.3
doaj  

Serogroup B meningococcal vaccines booster doses : Work Group interpretation, considerations for policy options, and next steps [PDF]

Meningococcal-5-Mbaeyi-508 ...

core  

4CMenB journey to the 10-year anniversary and beyond

Human Vaccines & Immunotherapeutics
The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 countries worldwide.
Véronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, Terry Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza   +10 more
doaj   +1 more source

Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. [PDF]

Virulence, 2019
Muenstermann M, Strobel L, Klos A, Wetsel RA, Woodruff TM, Köhl J, Johswich KO.   +6 more
europepmc   +1 more source